Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis

被引:18
|
作者
Xiong, Liu-Lin [1 ,3 ,4 ]
Du, Ruo-Lan [1 ,2 ]
Xue, Lu-Lu [2 ]
Jiang, Ya [2 ]
Huang, Jin [2 ]
Chen, Li [1 ]
Liu, Jia [2 ]
Wang, Ting-Hua [1 ,2 ]
机构
[1] Sichuan Univ, Inst Neurol Dis, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Peoples R China
[2] Kunming Med Univ, Inst Neurosci, Anim Zool Dept, Kunming 650000, Yunnan, Peoples R China
[3] Zunyi Med Univ, Affiliated Hosp, Dept Anesthesiol, Zunyi 563000, Guizhou, Peoples R China
[4] Univ South Australia, Sch Pharm & Med Sci, Div Hlth Sci, Adelaide, SA, Australia
基金
中国国家自然科学基金;
关键词
Colorectal cancer; Scutellarin; Antitumor effect; Genomics; proteomics; TRADITIONAL CHINESE MEDICINE; CELL-PROLIFERATION; FAMILY-HISTORY; APOPTOSIS; ANGIOGENESIS; MIGRATION; GROWTH;
D O I
10.1186/s13020-020-00307-z
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background Colorectal cancer, one of the most common digestive tumors with high mortality and morbidity worldwide, currently lacks effective therapies available to improve the prognosis. This study was aimed to investigate the potency of Scutellarin against colorectal cancers, and explore the related mechanism via genomic and proteomic analysis. Methods Cell counting kit-8 assay was employed to detect the viability of HCT-116 and RKO cell lines treated with Scutellarin. The apoptosis of HCT-116 and RKO cells after Scutellarin administration was determined by TUNEL staining and Caspase 3/7 activity. Cell cycle was detected by flow cytometry analysis. The wound healing and transwell invasion test detected the role of Scutellarin in migration and invasion of HCT-116 and RKO cells. Meanwhile, the energy metabolism and growth of tumor tissues in vivo at day 28 were observed by PET-CT after Scutellarin administration with 50 mg/kg, 100 mg/kg and 300 mg/kg into 4-week-old nude mice. Blood routine and liver functions were also detected to evaluate the side effect of Scutellarin. Furthermore, the disease and function classifications which the differentially expressed genes and proteins involved after Scutellarin treatment were determined by genomic and proteomic analysis respectively. Results The Scutellarin inhibited the migration and increased apoptosis of HCT-116 and RKO cell lines. Besides, Scutellarin treatment substantially decreased the growth and volume of colorectal tumors in nude mice without side effects on the blood routine and liver function. The differentially expressed genes in RKO cells after Scutellarin administration were mainly enriched in cell death and survival, organismal injury and abnormalities, and cancer. In addition, forty-seven upregulated and twenty-nine downregulated proteins were identified. Functional clustering analysis exhibited enriched biological processes, cellular components, molecular functions and related pathways of these proteins in cellular metabolic. Then protein-protein interactions analysis showed the regulatory relationship among these differentially expressed proteins. Conclusions Taken together, the present findings revealed that Scutellarin exerted significant antitumor effect with no side effects in the blood and liver by regulating various important molecules in tumor proliferation, apoptosis and metastasis.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Characterization of an Alginate Encapsulated LS180 Spheroid Model for Anti-colorectal Cancer Compound Screening
    Smit, Tanya
    Calitz, Carlemi
    Willers, Clarissa
    Svitina, Hanna
    Hamman, Josias
    Fey, Stephen J.
    Gouws, Chrisna
    Wrzesinski, Krzysztof
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (05): : 1014 - 1021
  • [42] Network pharmacology alliance with experimental validation unveils the anti-colorectal cancer mechanism of Xianlian Jiedu decoction
    Fan, Xiaoxuan
    Yan, Qiuying
    Xu, Weicheng
    Chen, Hui
    Xu, Yanru
    Lu, Sicheng
    Xu, Changliang
    Tan, Jiani
    Yu, Chengtao
    Lai, Yueyang
    Fan, Minmin
    Tao, Lihuiping
    Li, Liu
    Shen, Weixing
    Cheng, Haibo
    Sun, Dongdong
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 342
  • [43] Molecular Docking Studies of Glycyrrhetinic Acid Derivatives as Anti-Colorectal Cancer Agents
    Doan, Nam Q. H.
    Truong, Tuyen N.
    Nguyen, Phuong T. V.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2021, 17 (03) : 429 - 444
  • [44] AMPK-autophagy inhibition sensitizes icaritin-induced anti-colorectal cancer cell activity
    Zhou, Chunxian
    Gu, Jun
    Zhang, Gang
    Dong, Da
    Yang, Qunying
    Chen, Min-Bin
    Xu, Dongfeng
    ONCOTARGET, 2017, 8 (09) : 14736 - 14747
  • [45] Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate
    You, Si-yuan
    Rui, Wen
    Chen, Shuai-tong
    Chen, Hong-ce
    Liu, Xia-wan
    Huang, Jun
    Chen, Hong-yuan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 513 (04) : 891 - 897
  • [46] Proteomic analysis of colorectal cancer: discovering novel biomarkers
    Skandarajah, Anita R.
    Moritz, Robert L.
    Tjandra, Joe J.
    Simpson, Richard J.
    EXPERT REVIEW OF PROTEOMICS, 2005, 2 (05) : 681 - 692
  • [47] Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family
    Peltier, Julien
    Roperch, Jean-Pierre
    Audebert, Stephane
    Borg, Jean-Paul
    Camoin, Luc
    JOURNAL OF PROTEOMICS, 2016, 148 : 139 - 148
  • [48] Benzochalcones bearing pyrazoline moieties show anti-colorectal cancer activities and selective inhibitory effects on aurora kinases
    Shin, Soon Young
    Yoon, Hyuk
    Hwang, Doseok
    Ahn, Seunghyun
    Kim, Dong-Wook
    Koh, Dongsoo
    Lee, Young Han
    Lim, Yoongho
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (22) : 7018 - 7024
  • [49] Synthesis and Cytotoxicity Assay of Aniline Substituted Thienopyrimidines for Anti-Colorectal Cancer Activity
    Biradar, Mahalakshmi Suresha
    Nargund, Shachindra L.
    Thapa, Shankar
    RESULTS IN CHEMISTRY, 2023, 5
  • [50] Colorectal Cancer Biomarkers Discovery Approach: A Proteomic and Genomic Perspective
    Al-Zahrani, Maryam Hassan
    JOURNAL OF BIOCHEMICAL TECHNOLOGY, 2023, 14 (03) : 6 - 12